Emerging infectious diseases: Focus on infection control issues for novel coronaviruses (Severe Acute Respiratory Syndrome-CoV and Middle East Respiratory Syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza viruses, A(H5N1) and A(H7N9)

American Journal of Infection Control

Volumn 44, Issue 5, 2016, Pages e91-e100

  Weber, David J ^a,b   Rutala, William A ^a,b   Fischer, William A ^b   Kanamori, Hajime ^a,b   Sickbert Bennett, Emily E ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Ebola viral disease; Emerging infectious diseases; health care associated infections; infection control; Lassa fever; Middle East respiratory syndrome; novel influenza viruses; occupational health; severe acute respiratory disease

Indexed keywords

ACUTE RESPIRATORY TRACT DISEASE; ARTICLE; CLINICAL FEATURE; COMMUNICABLE DISEASE; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; HEALTH CARE FACILITY; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INFECTION CONTROL; INFLUENZA A VIRUS (H5N1); INFLUENZA A VIRUS (H7N9); LASSA FEVER; LASSA VIRUS; MICROBIOLOGY; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; SARS CORONAVIRUS; GLOBAL HEALTH; ORGANIZATIONAL POLICY; PROCEDURES; VIRUS INFECTION;

COMMUNICABLE DISEASES, EMERGING; GLOBAL HEALTH; HUMANS; INFECTION CONTROL; ORGANIZATIONAL POLICY; VIRUS DISEASES;

EID: 84971644025     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2015.11.018     Document Type: Article

References (125)

1. N. Bristol Obituary: William H. Stewart Lancet 372 2008 110
2. B. Spellberg, and B. Taylor-Blake On the exoneration of Dr. William H. Stewart: debunking an urban legend Infect Dis Poverty 2 2013 3
3. D.W. Fraser, T.R. Tsai, W. Orenstein, W.E. Parkin, H.J. Beecham, R.G. Sharrar, and et al. Legionnaires' disease: description of an epidemic of pneumonia N Engl J Med 297 1977 1189 1197
4. J.E. McDade, C.C. Shepard, D.W. Fraser, T.R. Tsai, M.A. Redus, and W.R. Dowdle Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease N Engl J Med 297 1977 1197 1203
5. Centers for Disease Control and Prevention Pneumonia - Los Angeles MMWR Morb Mortal Wkly Rep 30 1981 1 3
6. Centers for Disease Control and Prevention Pneumocystis carinii pneumonia among persons with hemophilia A MMWR Morb Mortal Wkly Rep 31 1982 365 367
7. F. Barre-Sinoussi, J.C. Chermann, F. Rey, M.T. Nugeyre, S. Chamaret, J. Gruest, and et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for Acquired Immune Deficiency Syndrome (AIDS) Science 220 1983 868 871
8. J. Hemelaar The origin and diversity of the HIV-1 pandemic Trends Mol Med 18 2012 182 192
9. Institute of Medicine Emerging infections: microbial threats to health in the United States 1992 National Academy Press Washington, DC
10. Institute of Medicine Microbial threats to health: emergence, detection, and response 2001 National Academy Press Washington, DC
11. World Health Organization Emerging diseases Available from: http://www.who.int/topics/emerging-diseases/en/ Accessed September 20, 2015
12. Centers for Disease Control and Prevention EID journal background and goals Available from: http://wwwnc.cdc.gov/eid/page/background-goals Accessed September 20, 2015
13. M.E. Wilson Travel and the emergence of infectious diseases Emerg Infect Dis 1 1995 39 46
14. M.E.J. Woolhouse, and S. Gowtage-Sequeria Host range and emerging and reemerging pathogens Emerg Infect Dis 11 2005 1842 1847
15. M.E.J. Woolhouse, D.T. Haydon, and R. Antia Emerging pathogens: the epidemiology and evolution of species jumps Trends Ecol Evol 20 2005 238 244
16. W.B. Karesh, A. Dobson, J.O. Lloyd-Smith, J. Lubroth, M.A. Dixon, M. Bennett, and et al. Ecology of zoonoses: natural and unnatural histories Lancet 380 2012 1936 1945
17. B.L. Pike, K.E. Saylors, J.N. Fair, M. Lebreton, U. Tamoufe, C.F. Djoko, and et al. The origin and prevention of epidemics Clin Infect Dis 50 2010 1636 1640
18. S.S. Morse, J.A. Mazel, M. Woolhouse, C.R. Parrish, D. Carroll, W.B. Karesh, and et al. Prediction and prevention of the next pandemic zoonosis Lancet 380 2012 1956 1965
19. M. Woolhouse, F. Scott, Z. Hudson, R. Howey, and M. Chase-Topping Human viruses: discovery and emergence Philos Trans R Soc Lond B Biol Sci 367 2012 2864 2871
20. S.S. Morse Factors in the emergence of infectious diseases Emerg Infect Dis 1 1995 7 14
21. S.J. Cutler, A.R. Fooks, and W.H.M. van der Poel Public health threat or new, reemerging, and neglected zoonoses in the industrialized world Emerg Infect Dis 16 2010 1 7
22. Centers for Disease Control and Prevention Information by emerging or reemerging infectious diseases topic Available from: http://www.cdc.gov/ncidod/diseases/eid/disease-sites.htm Accessed September 20, 2015
23. M.E.J. Woolhouse Population biology of emerging and re-emerging pathogens Trends Microbiol 10 Suppl 2002 S3 7
24. M.E.J. Woolhouse, R. Howey, E. Gaunt, L. Reilly, M. Chase-Topping, and N. Savill Temporal trends in the discovery of human viruses Proc Biol Sci 275 2008 2111 2115
25. B.A. Cunha, A. Burillo, and E. Bouza Legionnaires' disease Lancet 2015 10.1016/S0140-6736(15)60078-2 epub ahead of print
26. J.W. Ironside Variant Creutzfeldt-Jakob disease: an update Folia Neuropathol 50 2012 50 56
27. T.J. Gray, and C.E. Webb A review of the epidemiology and clinical aspects of West Nile virus Int J Gen Med 7 2014 193 203
28. D.B. Di Giulio, and P.B. Eckburg Human monkeypox: an emerging zoonoses Lancet Infect Dis 4 2004 15 25
29. M.E.J. Woolhouse Emerging diseases go global Nature 451 2008 898 899
30. M.E. Stryjewski, and G.R. Corey Methicillin-resistant Staphylococcus aureus: an evolving pathogen Clin Infect Dis 58 Suppl 1 2014 S10 9
31. T. O'Driscoll, and C.W. Crank Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management Infect Drug Resist 8 2015 217 230
32. P. Savard, and T.M. Perl A call for action: managing the emergence of multidrug-resistant Enterobacteriaceae in the acute settings Curr Opin Infect Dis 25 2012 371 377
33. T. Tangden, and C.G. Giske Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control J Intern Med 277 2015 501 512
34. D.A. Leffler, and J.T. Lamont Clostridium difficile infection N Engl J Med 375 2015 1539 1548
35. E. Robilotti, S. Deresinski, and B.A. Pinsky Norovirus Clin Microbiol Rev 28 2015 134 164
36. Centers for Disease Control and Prevention Mumps cases Available from: http://www.cdc.gov/mumps/outbreaks.html Accessed September 25, 2015
37. Centers for Disease Control and Prevention Measles cases Available from: http://www.cdc.gov/measles/cases-outbreaks.html Accessed September 25, 2015
38. Centers for Disease Control and Prevention Pertussis cases by year (1922-2014) Available from: http://www.cdc.gov/pertussis/surv-reporting/cases-by-year.html Accessed September 25, 2015
39. D.J. Weber, and W.A. Rutala Risks and prevention of nosocomial transmission of rare zoonotic diseases Clin Infect Dis 32 2001 446 456
40. L. Borio, T. Inglesby, C.J. Peters, A.L. Schmaljohn, J.M. Hughes, P.B. Jahrling, and et al. Hemorrhagic fever viruses as biological weapons: medical and public health management JAMA 287 2002 2391 2405
41. A. Srinivasan, L.C. McDonald, D. Jernigan, R. Helfand, K. Ginsheimer, J. Jernigan, and et al. Foundations of the severe acute respiratory syndrome preparedness and response plan for healthcare facilities Infect Control Hosp Epidemiol 25 2004 1020 1025
42. B. Gamage, D. Moore, R. Copes, A. Yassi, and E. Bryce Protecting health care workers from SARS and other respiratory pathogens: a review of the infection control literature Am J Infect Control 33 2005 114 121
43. A. Aprisarnthanarak, and L.M. Mundy Infection control for emerging infectious diseases in developing countries and resource-limited settings Infect Control Hosp Epidemiol 27 2006 885 887
44. N. Suwantarat, and A. Aprisarnthanarak Risks to healthcare workers with emerging infectious diseases: lessons from MERS-CoV, Ebola, SARS, and avian flu Curr Opin Infect Dis 28 2015 349 361
45. W.A. Rutala, and D.J. Weber Registration of disinfectants based on relative microbiocidal activity Infect Control Hosp Epidemiol 25 2004 333 341
46. S. Gunther, and O. Lenz Lassa virus Crit Rev Clin Lab Sci 41 2004 339 390
47. J.K. Raymond, and D.J. Baglobe Lassa fever: epidemiology, clinical features, and social consequence BMJ 327 2003 1271 1275
48. D. Grady Lassa fever carries little risk to public, experts say Available from: http://www.nytimes.com/2015/05/27/science/lassa-virus-carries-little-risk-to-public-experts-say.html Accessed September 25, 2015
49. L. Ftika, and H.C. Maltezou Viral haemorrhagic fevers in healthcare settings J Hosp Infect 83 2013 185 192
50. R.M. Sweighaft, D.W. Fraser, M.A.W. Hattwick, W.G. Winkler, W.C. Jordan, M. Alter, and et al. Lassa fever: response to an imported case N Engl J Med 297 1977 803 807
51. G.P. Holmes, J.B. McCormick, S.C. Trock, R.A. Chase, S.M. Lewis, C.A. Mason, and et al. Lassa fever in the United States N Engl J Med 323 1990 1120 1123
52. Centers for Disease Control and Prevention Imported Lassa fever - New Jersey, 2004 MMWR Morb Mortal Wkly Rep 53 2004 894 897
53. Centers for Disease Control and Prevention Lassa fever reported in U.S. traveler returned from West Africa Available from: http://www.cdc.gov/media/releases/2014/p0404-lassa-fever.html Accessed September 25, 2015
54. S.P. Fisher-Hoch, O. Tomori, A. Nasidi, G.I. Perez-Oronoz, Y. Fakile, L. Hutwagner, and et al. Review of nosocomial Lassa fever in Nigeria: the high price of poor medical practice BMJ 311 1995 857 859
55. B. Bannister Viral haemorrhagic fevers imported into non-endemic countries: risk assessment and management Br Med Bull 95 2010 193 225
56. D.G. Baasch, C.M. Hadi, S.H. Khan, and J.J.L. Lertora Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever Clin Infect Dis 51 2010 1435 1441
57. M.G. Madariage Ebola virus disease: a perspective for the United States Am J Med 128 2015 682 691
58. S. Rewar, and D. Mirdha Transmission of Ebola virus: an overview Ann Global Health 80 2014 444 451
59. P. Shears, and T.J.D. O'Dempsey Ebola virus disease in Africa: epidemiology and nosocomial transmission J Hosp Infect 90 2015 1 9
60. M.J. Murray Ebola virus disease: a review of its past and present Anesth Analg 121 2015 798 809
61. W.B. Lui, Li Z.X., Du Y., and Cao G.W. Ebola virus disease: from epidemiology to prophylaxis Mil Med 2 2015 7
62. K.L. Koenig, C. Majestic, and M.J. Burns Ebola virus disease: essential public health principles for clinicians West J Emerg Med 15 2014 728 731
63. Na W., N. Park, M. Yeom, and Song D. Ebola outbreak in western Africa 2014: what is going on with Ebola virus? Clin Exp Vaccine Res 4 2015 17 22
64. M.J. Martinez, A.M. Salim, J.C. Hurtado, and P.E. Kilgore Ebola virus infection: overview and update on prevention and treatment Infect Dis Ther 2015 10.1007/s40121-015-0079-5
65. W.A. Fischer, T.M. Uyeki, and R.V. Tauxe Ebola virus disease: what clinicians in the United States need to know Am J Infect Control 43 2015 788 793
66. D.J. Weber, W.A. Fischer, D.A. Wohl, and W.A. Rutala Protecting healthcare personnel from acquiring Ebola virus disease Infect Control Hosp Epidemiol 36 2015 1229 1232
67. A.L. Hewlett, J.B. Varkey, P.W. Smith, and B.S. Ribner Ebola virus disease: preparedness and infection control lessons from two biocontainment units Curr Opin Infect Dis 28 2015 343 348
68. B.W.M. Cook, T.A. Cutts, A.M. Nikiforuk, P.G. Poliquin, D.A. Court, J.E. Strong, and et al. Evaluating environmental persistence and disinfection of the Ebola virus Makona variant Viruses 7 2015 1975 1986
69. T.J. Piercy, S.J. Smither, J.A. Steward, L. Eastaugh, and M.S. Lever The survival of filoviruses in liquids, on solid substances and in a dynamic aerosol J Appl Microbiol 109 2010 1531 1539
70. M. Eggers, M. Eichmann, K. Kowalski, J. Zorn, and K. Reimer Povidone-iodine hand wash and hand rub products demonstrate excellent in vitro virucidal efficacy against Ebola virus and modified vaccinia virus Ankara, the new European test virus for enveloped viruses BMC Infect Dis 15 2015 375
71. J.S.M. Peiris, Guan Y., and K.Y. Yuen Severe acute respiratory syndrome Nat Med 10 Suppl 2004 S88 97
72. J.F. Chan, S.K.P. Lau, K.W. To, Cheng V.C.C., P.C.Y. Woo, and K.-Y. Yuen Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease Clin Microbiol Rev 28 2015 465 522
73. Hui D.S.C., and P.K.S. Chan Severe acute respiratory syndrome and coronavirus Infect Dis Clin North Am 24 2010 619 638
74. M.D. Christian, S.M. Poutanen, M.R. Loutfy, M.P. Muller, and D.E. Low Severe acute respiratory syndrome Clin Infect Dis 38 2004 1420 1427
75. D.J. Cleri, A.J. Ricketti, and J.R. Vernaleo Severe acute respiratory syndrome (SARS) Infect Dis Clin North Am 24 2010 175 202
76. Cheng V.C.C., J.F.W. Chan, K.T.W. To, and K.Y. Yuen Clinical management and infection control of SARS: lessons learned Antiviral Res 100 2013 407 419
77. A. Wilder-Smith, and J.G.H. Low Risk of respiratory infection in health care workers: lessons on infection control emerge from the SARS outbreak Southeast Asian J Trop Med Public Health 36 2005 481 488
78. P. Vijayanand, E. Wilkins, and M. Woodhead Severe acute respiratory syndrome (SARS): a review Clin Med 4 2004 152 160
79. R.P. Wenzel, G. Bearman, and M.B. Edmond Lessons from severe acute respiratory syndrome (SARS): implications for infection control Arch Med Res 36 2005 610 616
80. M.-Y. Yen, Lin Y.E., Su I.-J., Huang F.Y., M.S. Ho, Chang S.C., and et al. Using an integrated infection control strategy during outbreak control to minimize nosocomial infection of severe acute respiratory syndrome among healthcare workers J Hosp Infect 62 2006 195 199
81. I.C. Fung, and S. Cairncross Effectiveness of handwashing in preventing SARS: a review Trop Med Int Health 11 2006 1749 1758
82. Lai M.Y.Y., Cheng P.K.C., and W.W.L. Lim Survival of severe acute respiratory coronavirus Clin Infect Dis 41 2005 e67 71
83. C. Geller, M. Varbanov, and R.E. Duval Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies Viruses 4 2012 3044 3068
84. J. Sizun, Yu M.W.N., and P.J. Talbot Survival of human coronaviruses 229E and OC43 in suspension and after drying on surfaces: a possible source of hospital-acquired infections J Hosp Infect 46 2000 55 60
85. L. Casanova, W.A. Rutala, D.J. Weber, and M.D. Sobsey Coronavirus survival on healthcare personal protective equipment Infect Control Hosp Epidemiol 31 2010 560 561
86. J.A. Al-Tawfiq Middle East respiratory syndrome - coronavirus infection: an overview J Infect Public Health 6 2013 319 322
87. P. Sampathkumar Middle East respiratory syndrome: what clinicians need to know Mayo Clin Proc 89 2014 1153 1158
88. S. Alsolamy Middle East respiratory syndrome: knowledge to date Crit Care Med 43 2015 1283 1290
89. G.R. Banik, G. Khandaker, and H. Rashid Middle East respiratory syndrome "MERS-CoV": current knowledge gags Paediatr Respir Rev 16 2015 197 202
90. A. Assiri, J.A. Al-Tawfiq, A.A. Al-Rabeeah, F.A. Al-Rabiah, S. Al-Hajjar, A. Al-Barrak, and et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study Lancet Infect Dis 13 2013 752 761
91. A. Zumla, Hui D.S., and S. Perlman Middle East respiratory syndrome Lancet 386 2015 995 1007
92. Hui D.S., Z.A. Memish, and A. Zumla Severe acute respiratory syndrome vs. the Middle East respiratory syndrome Curr Opin Pulm Med 20 2014 233 241
93. J.A. Al-Tawfiq, and T.M. Perl Middle East respiratory syndrome coronavirus in healthcare settings Curr Opin Infect Dis 28 2015 392 396
94. J.A. Al-Tawfiq, and Z.A. Memish Middle East respiratory syndrome coronavirus: transmission and phylogenetic evolution Trends Microbiol 2014 573 579
95. S.A. Rasmussen, S.I. Gerber, and D.L. Swerdlow Middle East respiratory syndrome coronavirus: update for clinicians Clin Infect Dis 60 2015 1686 1689
96. H.C. Maltezou, and S. Tsiodras Middle East respiratory syndrome: implications for health care facilities Am J Infect Control 42 2014 1261 1265
97. M.M. Al-Abdallat, D.C. Payne, S. Alqasrawi, B. Rha, R.A. Tohme, G.R. Abedi, and et al. Hospital-associated outbreak of Middle East Respiratory Syndrome coronavirus: a serologic, epidemiologic, and clinical description Clin Infect Dis 59 2014 1225 1233
98. H.Y. Park, E.J. Lee, Y.W. Ryu, H. Kim, H. Lee, and Yi S.J. Epidemiologic investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015 Euro Surveill 20 2015 1 6
99. M. Ki 2015 MERS outbreak in Korea: hospital-to-hospital transmission Epidemiol Health 37 2015 e2015033
100. Centers for Disease Control and Prevention Interim infection prevention and control recommendations for hospitalized patients with Middle East Respiratory syndrome coronavirus (MERS-CoV) Available from: http://www.cdc.gov/coronavirus/mers/infection-prevention-control.html Accessed September 25, 2014
101. N. van Doremalen, T. Bushmaker, and V.J. Munster Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions Euro Surveill 18 2013 1 4
102. L.M. Casanova, S. Jeon, W.A. Rutala, D.J. Weber, and M.D. Sobsey Effects of air temperature and relative humidity on coronavirus survival on surfaces Appl Environ Microbiol 76 2010 2712 2717
103. R.L. Hulkower, L.M. Casanova, W.A. Rutala, D.J. Weber, and M.D. Sobsey Inactivation of surrogate coronaviruses on hard surfaces by health care germicides Am J Infect Control 39 2011 401 407
104. E. De Wit, and R.A.M. Fouchier Emerging influenza J Clin Virol 41 2008 1 6
105. P.N.Q. Pascua, and Y.K. Choi Zoonotic infections with avian influenza A viruses and vaccine preparedness: a game of "mix and match." Clin Exp Vaccine Res 3 2014 140 148
106. A.W. Hampson, and J.S. Mackenzie The influenza viruses Med J Aust 185 Suppl 2006 S39 43
107. L. Rudenko, C. Sellwood, C. Russell, S. Herfst, D. Gross, and R. Dingwall Will there ever be a new influenza pandemic and are we prepared? Vaccine 2015 10.1016/j.vaccine.2015.08.045 epub ahead of print
108. S. Herfst, M. Imai, Y. Kawaoka, and R.A.M. Fouchier Avian influenza virus transmission to mammals Curr Top Microbiol Immunol 385 2014 137 155
109. R.G. Webster, and E.A. Govorkova Continuing challenges in influenza Ann N Y Acad Sci 1323 2014 115 139
110. C. Trombetta, S. Piccirella, D. Perini, O. Kistner, and E. Montomoli Emerging influenza strains in the last two decades: a threat of a new pandemic? Vaccines 3 2015 172 185
111. D. Kalthoff, A. Globig, and M. Beer (Highly pathogenic) avian influenza as a zoonotic agent Vet Microbiol 140 2010 237 245
112. World Health Organization Avian influenza Available from: http://www.who.int/mediacentre/factsheets/avian-influenza/en/ Accessed September 25, 2015
113. Hui D.S., and A. Zumla Emerging respiratory tract viral infections Curr Opin Pulm Med 21 2015 284 292
114. Y. Poovorawan, S. Pyungporn, S. Prachayangprecha, and J. Makkoch Global alert to avian influenza virus infection: from H5N1 to H7N9 Pathog Glob Health 107 2013 217 223
115. D.U. Pfeiffer, M.J. Otte, D. Roland-Holst, K. Inui, N. Tung, and D. Zilberman Implications of global and regional patterns of highly pathogenic avian influenza virus H5N1 clades for risk management Vet J 190 2011 309 316
116. D.B. Jernigan, and N.J. Cox H7N9: preparing for the unexpected in influenza Annu Rev Med 66 2015 361 371
117. T. Watanabe, S. Watanabe, E.A. Maher, G. Neumann, and Y. Kawaoka Pandemic potential of avian influenza A (H7N9) viruses Trends Microbiol 22 2014 623 631
118. K.K.W. To, J.H.F.W. Chan, and K.-Y. Yuen Viral lung infections: epidemiology, virology, clinical features, and management of avian influenza A(H7N9) Curr Opin Pulm Med 20 2014 225 232
119. J. Iskander, R.A. Strikas, K.F. Gensheimer, N.J. Cox, and S.C. Redd Pandemic influenza planning, United States, 1978-2008 Emerg Infect Dis 19 2013 879 885
120. World Health Organization Pandemic influenza preparedness and response Available from: http://www.who.int/influenza/resources/documents/pandemic-guidance-04-2009/en/ Accessed September 25, 2015
121. Centers for Disease Control and Prevention Updated preparedness and response framework for influenza pandemics MMWR Morb Mortal Wkly Rep 63 2014 1 18
122. J.P. Wood, Y.W. Choi, D.J. Chappie, J.V. Rogers, and J.Z. Kaye Environmental persistence of a highly pathogenic avian influenza (H5N1) virus Environ Sci Technol 44 2010 7515 7520
123. S. Wanaratana, R. Tantiletcharoen, J. Sasipreeyajan, and S. Pakpinyo The inactivation of avian influenza virus subtype H5N1 isolated from chickens in Thailand by chemical and physical treatments Vet Microbiol 140 2010 43 48
124. E.W. Rice, N.J. Adcock, M. Sivaganesan, J.D. Brown, D.E. Stallknecht, and D.E. Swayne Chlorine inactivation of highly pathogenic avian influenza virus (H5N1) Emerg Infect Dis 13 2007 1568 1570
125. D.Y. Oh, and A.C. Hurt A review of the antiviral susceptibility of human and avian influenza viruses over the last decade Scientifica (Cairo) 2014 2014 430629